Mark Booth

Mark Booth is Executive Vice President, Commercial Operations of TerSera Therapeutics. Previously Mark was Chief Commercial Officer at Assertio Therapeutics and Orexigen Therapeutics.

Mark brings extensive commercial experience to TerSera having led commercial organizations in big pharma, biopharma and specialty pharmaceutical companies. Prior to Assertio and Orexigen, Mark was President of Takeda Pharmaceuticals North America for approximately 7 years. He also served as General Manager and Senior Vice President of Commercial Operations at Immunex Corporation.

Mark began his pharmaceutical career at Abbott, and over 17 years held multiple positions of increasing responsibility with his last role being Division Vice President, General Manager for the Anti-Infective Franchise.

Mark holds a B.S. from Northern Illinois University and an M.B.A from the J.L Kellogg Graduate School of Management from Northwestern University.